During the past decade, NorthShore University HealthSystem conducted 176 clinical trials. In the 10-year time frame, 176 clinical trials started and 104 clinical trials were completed, i.e. on average, 59.1% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 66 clinical trials were completed. i.e. 83.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NorthShore University HealthSystem" #1 sponsor was "NorthShore University HealthSystem" with 48 trials, followed by "University of Chicago" with 21 trials sponsored, "Abbott Medical Devices" with 6 trials sponsored, "Novartis Pharmaceuticals" with 6 trials sponsored and "Takeda" with 6 trials sponsored. Other sponsors include 199 different institutions and companies that sponsored additional 147 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NorthShore University HealthSystem" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NorthShore University HealthSystem" with 11 trials as a collaborator, "University of Chicago" with 7 trials as a collaborator, "Northwestern University" with 5 trials as a collaborator and "Genentech, Inc." with 4 trials as a collaborator. Other collaborators include 182 different institutions and companies that were collaborators in the rest 161 trials.

According to Clinical.Site data, the most researched conditions in "NorthShore University HealthSystem" are "Prostate Cancer" (11 trials), "Breast Cancer" (10 trials), "Atrial Fibrillation" (6 trials), "COVID-19" (5 trials) and "Heart Failure" (5 trials). Many other conditions were trialed in "NorthShore University HealthSystem" in a lesser frequency.

Most popular intervention types in "NorthShore University HealthSystem" are "Drug" (153 trials), "Device" (69 trials), "Other" (43 trials), "Biological" (18 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "laboratory biomarker analysis" (7 trials), "placebo" (7 trials), "Methadone" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "NorthShore University HealthSystem" are 237 trials for "All" genders, 42 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are 93 active trials in "NorthShore University HealthSystem". 1 are not yet recruiting, 46 are recruiting, 41 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 144 completed trials in NorthShore University HealthSystem, 2 suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in NorthShore University HealthSystem, 16 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 81 trials that are defined as “Not Applicable".